Related Experiment Video
Updated: Mar 22, 2026

09:53
Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation
Published on: January 10, 2025
924
Exogenous H2S contributes to recovery of ischemic post-conditioning-induced cardioprotection by decrease of ROS level
Lina Li1,2, Meixiu Li1,2, Youyou Li1,2
1Department of Pathophysiology, Harbin Medical University, Baojian Road, Harbin, 150081 China.
Cell & Bioscience
|April 21, 2016
Summary
Hydrogen sulfide (H2S) restores protective effects of ischemic post-conditioning in aging heart cells by reducing oxidative stress. This finding offers new therapeutic avenues for age-related cardiovascular diseases.
Area of Science:
- Cardiovascular Science
- Cellular Biology
- Biochemistry
Background:
- Hydrogen sulfide (H2S) is a gasotransmitter vital for cardiovascular function.
- Ischemic post-conditioning (PC) protects against hypoxia/reoxygenation (H/R) injury but is ineffective in aging cardiomyocytes.
- The role of H2S in restoring PC cardioprotection in aged cells remains unclear.
Purpose of the Study:
- To investigate if exogenous H2S can restore PC-induced cardioprotection in aging cardiomyocytes.
- To determine if H2S mitigates H/R-induced injury and apoptosis by reducing reactive oxygen species (ROS).
Main Methods:
- Aging cardiomyocytes were induced using d-galactose and subjected to H/R and PC protocols.
- Cell viability, apoptosis, ROS levels, and protein expressions were assessed.
- H2S was supplied using NaHS (a donor), and its effects were compared to ROS and NF-κB inhibitors.
Main Results:
- NaHS treatment protected aging cardiomyocytes against H/R injury, reducing apoptosis and cell damage.
- H2S supplementation decreased ROS levels and key apoptotic markers (caspase-3/9, Cyt c).
- NaHS restored PC efficacy in aging cells, comparable to ROS and NF-κB inhibitors.
Conclusions:
- Exogenous H2S restores PC-induced cardioprotection in aging cardiomyocytes.
- H2S acts by decreasing ROS levels through the down-regulation of NF-κB and JAK2/STAT3 pathways.

